**9. Conclusion**

MIS-C is a newly emerging disease that shares its clinical presentation simulating other serious pediatric diseases, which implies a diagnostic challenge for clinicians. Its pathophysiology is not well known but it is clear that it is a post-infectious immune syndrome. Life threatening is given by cardiac and vascular involvement. In the post-COVID era, the effort must then focus on maintaining the clinical search for the disease, maintaining vaccination of both adults and children, and in prioritizing less developed countries with poor access to vaccination.

*Post COVID-19 - Effects on Human Health*
